Aptus Pharma Ltd. benchmarking: Perfomance to industry peers

Financial

	Aptus Pharma	Zota Health Care	Sunrest Lifescience
Operational Metrics
Financials
5 yr Average ROE	36.58 %	-7.74 %	38.0 %
5yr average Equity Multiplier	5.05	1.84	5.71
5yr Average Asset Turnover Ratio	1.72	0.91	1.32
5yr Avg Net Profit Margin	6.16 %	-4.95 %	4.49 %
Price to Book	15.79	15.07	1.29
P/E	35.4	0.0	10.62
5yr Avg Cash Conversion Cycle	88.73 Days	40.5 Days	85.25 Days
Inventory Days	64.83 Days	91.82 Days	58.22 Days
Days Receivable	65.8 Days	42.2 Days	397.25 Days
Days Payable	77.01 Days	92.36 Days	220.86 Days
5yr Average Interest Coverage Ratio	6.23	5.98	26.66
5yr Avg ROCE	28.46 %	-2.72 %	24.04 %
5yr Avg Operating Profit Margin	10.95 %	3.69 %	7.01 %
5 yr average Debt to Equity	2.26	0.04	1.22
5yr CAGR Net Profit	74.79 %	206.06 %	20.84 %
5yr Average Return on Assets	8.44 %	-3.4 %	5.64 %
Shareholdings
Promoter Holding	72.89 %	55.81 %	53.5 %
Share Pledged by Promoters	0.0	0.26 %	0.0
Change in Promoter Holding (3 Yrs)	0.0	-12.31 %	-16.41 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.06 %	0.0

	Aptus Pharma	Zota Health Care	Sunrest Lifescience
Product Wise Break-Up	Product Wise Break-Up Finished Formulations 94.44 Commission 5.56 Retail Pharmacy 0 Export 0 0	Product Wise Break-Up Export 10.89 Finished Formulations 0 Marketing 21.65 Commission 0 Pharmacy 63.56 Others 3.9	Product Wise Break-Up Export 0 Finished Formulations 0 0 Commission 0 Retail Pharmacy 0 Others 100
Location Wise Break-Up	Location Wise Break-Up Gujarat 99.2 West bengal 0.8 Rest of the World 0 India 0	Location Wise Break-Up Gujarat 0 India 93.59 Rest of the World 6.41 West bengal 0	-
Therapeutic Area Break-Up	Therapeutic Area Break-Up Anti Infective 29.4 Anti-Allergy & Respiratory 19.6 Antacids and Gastrointestinal 17.2 Anti Inflammatory & Pain Management 10.0 Supplement 5.6 Others 18.2	-	-